Vericel Corporation (VCEL) Social Stream



Vericel Corporation (VCEL): $27.79

0.91 (+3.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VCEL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Vericel Corp (VCEL) Price Targets From Analysts

Use the tables below to see what analysts covering Vericel Corp think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $68.001 $62 $65.65 $39.58 65.87%
2021-12-01 5 $68 $54 $60.75 $39.58 53.49%
2022-01-12 5 $68 $52 $60.15 $39.58 51.97%
2022-01-18 5 $68 $52 $57.75 $39.58 45.91%
2022-01-24 5 $68 $40 $54.95 $39.58 38.83%
2022-02-01 5 $61.75 $40 $51.95 $39.58 31.25%
2022-02-25 5 $55.6 $40 $50.72 $39.58 28.15%
2022-02-28 5 $55.6 $44 $50.12 $39.58 26.63%

The Trend in the Analyst Price Target


Over the past 22 months, VCEL's average price target has gone up $26.72.

VCEL reports an average of 30.71% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-03 6 61.000 55.25 58.71 53.20 10.36%
2021-05-08 6 70.000 63.00 66.38 52.65 26.08%
2021-08-01 6 68.000 62.00 65.71 52.94 24.12%
2021-11-10 5 68.001 62.00 65.65 41.92 56.61%
2022-02-01 5 61.750 40.00 51.95 35.70 45.52%

VCEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 123 days, VCEL's average broker recommendation rating improved by 0.57.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Vericel Corp's upside potential (average analyst target price relative to current price) is higher than 152.85% of Pharmaceutical Products stocks.
  • In terms of how Vericel Corp fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -90.77% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Vericel Corp's number of analysts covering the stock is higher than 205.12% of them.
  • VCEL has a greater average analyst price target than 582.6% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Vericel Corp are TIL, SWTX, and SRNE.

Is VCEL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7824 seconds.